AVADEL PHARMACEUTICALS PLC

AVDL

AVADEL PHARMACEUTICALS PLC

AVDL

Insider Sentiment (TTM):

Last Purchase:2025-01-21Last Sale:2026-02-13Shares Purchased (TTM):0Shares Sold (TTM):11,112,052

Institutional Sentiment:

As of:2025-12-31Institutional Shares Owned:68,982,243Shares Outstanding:97,104,000Institutional Ownership Pct.:71.04%

Earnings Market Reaction:

Filing Date:2025-11-04Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Companies in Pharmaceutical Preparations

LLY JNJ ABBV MRK ABT PFE

AVADEL PHARMACEUTICALS PLC (AVDL) — SEC Financial Statements & Analysis

AVADEL PHARMACEUTICALS PLC (AVDL) files its annual 10-K and quarterly 10-Q reports directly with the SEC. The financial data below is sourced as-filed from EDGAR — balance sheet, income statement, and cash flow as reported, without normalization or third-party adjustments.

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value	80	63	56	51	29	29	36	31	52	50	83	74
Marketable Securities Current	12	18	10	22	37	43	53	74	101	111	18	23
Accounts Receivable Net Current	42	41	42	34	37	33	23	12	6	2	-	0
Inventory Net	24	23	20	20	16	13	12	10	5	1	-	0
Prepaid Expense And Other Assets Current	14	13	11	6	8	7	11	7	6	7	6	2
Assets Current	172	159	139	134	127	126	136	134	172	171	109	101
Property Plant And Equipment Net	0	0	0	0	0	0	1	1	1	1	1	1
Operating Lease Right Of Use Asset	3	3	3	2	2	2	2	3	3	1	1	2
Goodwill	17	17	17	17	17	17	17	17	17	17	17	17
Other Assets Noncurrent	7	8	9	11	12	12	12	10	10	11	11	11
Assets	199	187	168	164	158	158	168	165	203	201	141	133
Liabilities And Stockhold…
Liabilities Current
Long Term Debt Current	-	-	-	-	-	-	-	-	21	21	21	38
Operating Lease Liability Current	1	1	1	1	1	1	1	1	1	1	1	1
Accounts Payable Current	13	10	9	7	8	10	19	11	13	12	10	8
Accrued Liabilities Current	44	43	41	41	34	34	28	24	18	18	8	7
Senior Notes Current	-	-	-	-	-	-	-	0	-	-	-	38
Other Liabilities Current	5	3	0	0	0	0	0	0	1	1	0	2
Liabilities Current	62	57	51	49	43	45	48	37	54	52	79	56
Long Term Debt Noncurrent	-	-	-	-	-	-	-	-	-	0	93	92
Operating Lease Liability Noncurrent	2	2	2	1	1	1	1	2	2	0	1	1
Other Liabilities Noncurrent	2	2	5	5	5	6	6	6	6	6	6	6
Senior Long Term Notes	-	-	-	-	-	-	-	0	0	-	-	92
Liabilities	101	96	94	90	84	87	90	77	93	58	179	154
Stockholders Equity
Preferred Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Value	1	1	1	1	1	1	1	1	1	1	1	1
Additional Paid In Capital Common Stock	910	903	897	892	887	880	874	855	852	849	603	590
Retained Earnings Accumulated Deficit	-790	-790	-799	-794	-789	-787	-773	-745	-717	-680	-616	-585
Accumulated Other Comprehensive Income Loss Net Of…	-24	-24	-24	-25	-24	-24	-24	-23	-26	-26	-26	-26
Stockholders Equity	98	91	74	74	75	70	78	88	110	143	-38	-21
Liabilities And Stockholders Equity	199	187	168	164	158	158	168	165	203	201	141	133
Preferred Stock Par Or Stated Value Per Share	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01
Preferred Stock Shares Authorized	50	50	50	50	50	50	50	50	50	50	50	50
Preferred Stock Shares Issued	0	0	0	0	0	0	0	5	5	5	5	5
Preferred Stock Shares Outstanding	0	0	0	0	0	0	0	5	5	5	5	5
Common Stock Par Or Stated Value Per Share	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01
Common Stock Shares Authorized	500	500	500	500	500	500	500	500	500	500	500	500
Common Stock Shares Issued	97	97	97	97	96	96	96	90	89	89	64	63
Shares Outstanding	97	97	97	97	96	96	96	90	89	89	64	63

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2025	-3.80%	-2.85%	16.47%	15.86%	20.41%	45.68%	13.70%	14.23%	13.76%	-	-	-
2024	-1.85%	-13.48%	2.89%	-3.62%	-19.00%	-18.17%	-23.95%	-15.89%	-39.92%	6.09%	16.16%	20.93%
2023	-2.88%	-5.19%	-2.67%	4.12%	-19.84%	-23.50%	7.83%	21.51%	19.02%	34.74%	35.60%	21.21%
2022	-	-	-	-	-	-	61.95%	24.96%	28.80%	18.67%	60.40%	62.99%
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 50+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 50+ calculated metrics

Start free trial

Performance and Valuation Metrics

Metrics	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31
Liquidity Ratios
Current Ratio	2.76	2.79	2.73	2.75	2.97	2.82	2.85	3.64	3.19	3.32	1.38	1.81
Quick Ratio	2.14	2.14	2.12	2.21	2.41	2.37	2.36	3.18	2.97	3.17	1.30	1.77
Working Capital	109.74M	102.04M	88.33M	85.37M	84.48M	81.17M	88.23M	97.35M	118.20M	119.73M	30.11M	45.05M
Leverage & Debt
Debt to Equity	1.03	1.06	1.27	1.22	1.12	1.24	1.14	0.88	0.84	0.40	-4.69	-7.28
Interest Coverage TTM	0.47	0.22	-1.85	-3.91	-6.11	-10.25	-14.71	-13.94	-12.61	-9.52	-7.23	-7.99
Debt Ratio	0.51	0.52	0.56	0.55	0.53	0.55	0.53	0.47	0.46	0.29	1.27	1.16
Efficiency & Turnover
Asset Turnover TTM	1.39	1.28	1.16	1.03	0.76	0.53	0.36	0.19	0.05	0.01	0.00	0.00
Days Sales Outstanding TTM	58.42	61.09	60.32	49.86	57.25	67.42	150.21	157.98	267.60	433.07	-	-
Receivables Turnover TTM	6.25	5.97	6.05	7.32	6.38	5.41	2.43	2.31	1.36	0.84	-	-
Per Share Metrics
Diluted EPS TTM	-0.00	-0.03	-0.27	-0.51	-0.75	-1.10	-1.71	-2.00	-1.78	-1.85	-2.22	-2.29
Free Cash Flow Per Share TTM	0.35	0.05	-0.26	-0.49	-0.86	-1.19	-1.40	-1.60	-1.30	-1.10	-1.05	-1.18
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Margin Metrics
Gross Profit Margin TTM	94.91%	89.64%	90.06%	90.97%	91.92%	94.62%	95.71%	-	-	-	-	-
Operating Profit Margin TTM	1.82%	1.02%	-9.96%	-25.07%	-46.33%	-103.82%	-245.89%	-492.97%	-1,597.97%	-7,876.80%	-	-
Net Profit Margin TTM	-0.11%	-1.32%	-13.58%	-28.87%	-52.53%	-111.64%	-284.42%	-573.17%	-1,867.69%	-9,546.26%	-	-
Growth Metrics
Net Revenue Growth (1Y)	79.88%	132.35%	252.64%	504.79%	1,523.50%	6,260.23%	-	-	-	-	-	-
Net Income Growth (1Y)	-99.62%	-97.25%	-83.16%	-69.53%	-54.34%	-25.62%	10.58%	16.59%	20.12%	6.44%	57.04%	77.77%
EPS Growth (1Y)	-99.62%	-97.26%	-84.02%	-74.33%	-57.62%	-40.24%	-22.95%	-12.61%	-19.09%	-18.65%	44.60%	73.15%
Calculated Values
Free Cash Flow TTM	34.35M	5.27M	-25.44M	-46.91M	-82.81M	-114.15M	-127.98M	-128.51M	-115.85M	-85.14M	-67.21M	-71.02M
Net Debt	-79.81M	-63.40M	-56.37M	-51.37M	-28.58M	-28.85M	-35.79M	-31.17M	-30.62M	-29.13M	30.26M	55.30M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2026-02-13Sale

Owner: Weiss, Andrew M, Weiss As…

Title: -

Shares: 11,112,052

Price/Share: $21.00

Value: $233,353,092.00

Shares Owned: -

Relationship: Other

Ownership: Indirect

2025-01-21Purchase

Owner: Palczuk, Linda

Title: -

Shares: 5,000

Price/Share: $7.93

Value: $39,650.00

Shares Owned: 67,900

Relationship: Director

Ownership: Direct

2025-01-13Purchase

Owner: Ende, Eric J

Title: -

Shares: 30,000

Price/Share: $7.84

Value: $235,200.00

Shares Owned: 208,900

Relationship: Director

Ownership: Direct

2025-01-13Purchase

Owner: Thornton, Peter J.

Title: -

Shares: 10,000

Price/Share: $8.05

Value: $80,500.00

Shares Owned: 104,055

Relationship: Director

Ownership: Direct

2024-12-13Purchase

Owner: Mchugh, Thomas S

Title: Chief Financial Officer

Shares: 2,300

Price/Share: $10.44

Value: $24,012.00

Shares Owned: 87,800

Relationship: Officer

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2026-02-13	Weiss, Andrew M, Weiss As…	Other	-	Indirect	Sale	11,112,052	21.00	$233,353,092.00	0	4
2025-01-21	Palczuk, Linda	Director	-	Direct	Purchase	5,000	7.93	$39,650.00	67,900	4
2025-01-13	Ende, Eric J	Director	-	Direct	Purchase	30,000	7.84	$235,200.00	208,900	4
2025-01-13	Thornton, Peter J.	Director	-	Direct	Purchase	10,000	8.05	$80,500.00	104,055	4
2024-12-13	Mchugh, Thomas S	Officer	Chief Financial Officer	Direct	Purchase	2,300	10.44	$24,012.00	87,800	4
2024-12-11	Mchugh, Thomas S	Officer	Chief Financial Officer	Direct	Purchase	5,000	10.49	$52,450.00	85,500	4
2024-12-10	Glass, Geoffrey Michael	Director	-	Indirect	Purchase	20,279	9.85	$199,748.15	75,904	4
2024-12-09	Divis, Gregory J	Director,Officer	Chief Executive Officer	Indirect	Purchase	402	9.82	$3,947.64	10,000	4
2024-12-06	Palczuk, Linda	Director	-	Direct	Purchase	3,000	10.19	$30,570.00	66,400	4
2024-01-16	Mchugh, Thomas S	Officer	Chief Financial Officer	Direct	Purchase	2,000	14.50	$29,000.00	80,500	4
2023-12-28	Mccamish, Mark Anthony	Director	-	Indirect	Sale	75,000	14.53	$1,089,750.00	67,025	4
2023-08-14	Mchugh, Thomas S	Officer	Chief Financial Officer	Direct	Purchase	2,000	14.45	$28,900.00	78,500	4
2023-08-11	Mccamish, Mark Anthony	Director	-	Indirect	Sale	28,975	14.93	$432,596.75	142,025	4
2023-08-10	Divis, Gregory J	Director,Officer	Chief Executive Officer	Direct	Purchase	10,000	13.20	$132,000.00	159,100	4
2023-08-10	Glass, Geoffrey Michael	Director	-	Indirect	Purchase	14,000	13.40	$187,600.00	59,000	4
2023-05-18	Ende, Eric J	Director	-	Direct	Purchase	13,000	13.93	$181,090.00	167,900	4
2023-05-09	Palczuk, Linda	Director	-	Direct	Purchase	2,500	14.76	$36,900.00	52,400	4
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2025-12-31

71.04%

Inst. Shares: 68,982,243

Shares Outstanding: 97,104,000

2025-09-30

80.11%

Inst. Shares: 77,789,877

Shares Outstanding: 97,104,000

2025-06-30

81.56%

Inst. Shares: 78,885,527

Shares Outstanding: 96,726,000

2025-03-31

77.84%

Inst. Shares: 75,195,245

Shares Outstanding: 96,601,000

2024-12-31

81.98%

Inst. Shares: 77,994,899

Shares Outstanding: 95,141,000

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2025-12-31	68,982,243	97,104,000	71.04%
2025-09-30	77,789,877	97,104,000	80.11%
2025-06-30	78,885,527	96,726,000	81.56%
2025-03-31	75,195,245	96,601,000	77.84%
2024-12-31	77,994,899	95,141,000	81.98%
2024-09-30	71,666,590	96,300,000	74.42%
2024-06-30	65,728,900	96,151,000	68.36%
2024-03-31	67,766,983	91,693,000	73.91%
2023-12-31	52,417,091	80,174,000	65.38%
2023-09-30	51,771,308	89,380,000	57.92%
2023-06-30	50,105,999	77,246,000	64.87%
2023-03-31	46,566,263	63,886,000	72.89%
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

AVADEL PHARMACEUTICALS PLC (AVDL) — SEC Financial Statements & Analysis

Research Faster.Invest Smarter.

Research Faster.
Invest Smarter.